Correlation Between Apellis Pharmaceuticals and I Mab
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and I Mab at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and I Mab into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and I Mab, you can compare the effects of market volatilities on Apellis Pharmaceuticals and I Mab and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of I Mab. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and I Mab.
Diversification Opportunities for Apellis Pharmaceuticals and I Mab
-0.31 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Apellis and IMAB is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and I Mab in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on I Mab and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with I Mab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of I Mab has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and I Mab go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and I Mab
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 1.53 times more return on investment than I Mab. However, Apellis Pharmaceuticals is 1.53 times more volatile than I Mab. It trades about 0.19 of its potential returns per unit of risk. I Mab is currently generating about -0.39 per unit of risk. If you would invest 2,734 in Apellis Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 457.00 from holding Apellis Pharmaceuticals or generate 16.72% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. I Mab
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| I Mab |
Apellis Pharmaceuticals and I Mab Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and I Mab
The main advantage of trading using opposite Apellis Pharmaceuticals and I Mab positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, I Mab can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in I Mab will offset losses from the drop in I Mab's long position.| Apellis Pharmaceuticals vs. Eliem Therapeutics | Apellis Pharmaceuticals vs. HCW Biologics | Apellis Pharmaceuticals vs. Scpharmaceuticals | Apellis Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |